|
Dear Seed Investor,
InMed's addition to Canada’s Cannabis ETF Could Be Signalling the Start of a Big New Investing Theme: Biotechs
Horizons ETFs Management (Canada) Inc. announced it has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF on December 15, 2017. As a result, 11 new holdings have been added to HMMJ's portfolio.
HMMJ is the world's first ETF that offers direct exposure to North American-listed securities that are involved with marijuana bioengineering and production. The HMMJ portfolio has expanded to include the following constituents:
HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Marijuana Index (the "Index"), net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. The Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses related to the marijuana industry.
"Cannabis has been one of the newest and fastest-growing asset classes of 2017, presently valued at approximately$23 billion," said Steve Hawkins, President and Co-CEO of Horizons ETFs. "The continued expansion of HMMJ's Index and portfolio demonstrates how quickly this sector has evolved and why it should be considered a long-term, domestic investment opportunity for Canadian investors."
Rebalancing of the North American Marijuana Index occurs before the end of each calendar quarter. At that point, all stocks eligible for inclusion in the Index are weighted by their respective market capitalization. However, no single stock can exceed 10% of the weight of the index at the rebalance date.
Read the Full Release Here
High Profits,
The Seed Investor |
|
|
|